TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
29278689
DOI
10.1016/j.bbamcr.2017.12.006
PII: S0167-4889(17)30327-0
Knihovny.cz E-resources
- Keywords
- Apoptosis, Cancer, Necroptosis, Receptor-specific signaling, TRAIL,
- MeSH
- Apoptosis genetics MeSH
- HT29 Cells MeSH
- Caspase 8 genetics MeSH
- Colorectal Neoplasms genetics pathology MeSH
- Humans MeSH
- RNA, Small Interfering MeSH
- Pancreatic Neoplasms genetics pathology MeSH
- Necrosis genetics pathology MeSH
- NF-kappa B genetics MeSH
- Pancreas metabolism pathology MeSH
- Cell Proliferation genetics MeSH
- TNF-Related Apoptosis-Inducing Ligand genetics MeSH
- Gene Expression Regulation, Neoplastic MeSH
- Signal Transduction genetics MeSH
- Receptors, TNF-Related Apoptosis-Inducing Ligand genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Caspase 8 MeSH
- RNA, Small Interfering MeSH
- NF-kappa B MeSH
- TNF-Related Apoptosis-Inducing Ligand MeSH
- TNFRSF10A protein, human MeSH Browser
- TNFRSF10B protein, human MeSH Browser
- TNFSF10 protein, human MeSH Browser
- Receptors, TNF-Related Apoptosis-Inducing Ligand MeSH
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine that can trigger apoptosis in many types of human cancer cells via engagement of its two pro-apoptotic receptors TRAIL-R1 (DR4) and TRAIL-R2 (DR5). TRAIL can also activate several other signaling pathways such as activation of stress kinases, canonical NF-κB signaling and necroptosis. Though both receptors are ubiquitously expressed, their relative participation in TRAIL-induced signaling is still largely unknown. To analyze TRAIL receptor-specific signaling, we prepared Strep-tagged, trimerized variants of recombinant human TRAIL with high affinity for either DR4 or DR5 receptor. Using these receptor-specific ligands, we examined the contribution of individual pro-apoptotic receptors to TRAIL-induced signaling pathways. We found that in TRAIL-resistant colorectal HT-29 cells but not in pancreatic PANC-1 cancer cells, DISC formation and initial caspase-8 processing proceeds comparably via both DR4- and DR5-activated signaling. TRAIL-induced apoptosis, enhanced by the inhibitor of the Bcl-2 family ABT-737, or by the translation inhibitor homoharringtonine, proceeded in both cell lines predominantly via the DR5 receptor. ShRNA-mediated downregulation of DR4 or DR5 receptors in HT-29 cells also pointed to a stronger contribution of DR5 in TRAIL-induced apoptosis. In contrast to apoptosis, necroptotic signaling was activated similarly by both DR4- or DR5-specific ligands. Activation of auxiliary signaling pathways involving NF-κB or stress kinases proceeded under apoptotic conditions mainly in a DR5-dependent manner, while these signaling pathways were during necroptosis similarly activated by either of these ligands. Our study provides the first systematic insight into DR4-/DR5-specific signaling in colorectal and pancreatic cancer cells.
References provided by Crossref.org